Armenian parliament approves Government’s program

YEREVAN, May 23./ARKA/. Armenian parliament approved the government’s program for 2013-2017, ARKA correspondent reported Thursday.

Some 76 deputies of the coalitional parties, the Republican party and Orinats Yerkir, supported the program, and 41 deputies voted against it.

The new Cabinet of Armenia was assembled on May 8 after the presidential election of 18 February.
The government submitted its 2013-2017 program to the National Assembly on May 20.

The program mainly embraces five principal courses: safe and prosperous Armenia, creation of new jobs with a fair salary, free and fair Armenia, human capital and institutional development.

The current program has the same targets as the previous one, particularly, related to reaching the same economic growth, doubling the minimal wages, reducing poverty by 8-10%, creating 100,000 new jobs, ensuring growth in pensions and increasing the share of taxes in GDP structure.—0-

spot_img

POPULAR

Armenian banks’ investments in securities in the second quarter amounted to 1.92 trillion drams

The total volume of investments by Armenian commercial banks in securities as of the end of June 2026 amounted to 1,922,826,829 thousand drams.

Armenian dram weakened against the dollar and strengthened against the euro and ruble: Central Bank

The average market exchange rate for the US dollar to the Armenian dram, formed on the Armenian foreign exchange market as of August 24, 2026, increased by 0.22 points to 365.38 drams compared to August 21.

An Armenian Business Founded in a Garage: Games for Live Communication with the Support of Acba Bank

The success story of board games created by David Hovhannisyan began in a small garage near his home. David and his friends created educational games during their student years; as the number of orders grew, they decided to expand the business.

Armenia set to enhance development of its capital market, targeting large issuers and new investors

YEREVAN, August 20. /ARKA/. The Armenian government prioritizes diversifying funding sources and advancing the capital market to foster sustainable and productive economic growth.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

LATEST NEWS

spot_imgspot_imgspot_img